“The evolving regulatory status of CBD”, a paper I co-wrote with Dr. Jamie Corroon, was published this week on the popular Project CBD website.
Category: Products
Rod Speaks At Southern US Hemp Conference and Expo
I enjoyed sharing a panel to discuss hemp legal issues with my friends and fellow attorneys at the Southern US Hemp Conference and Expo this week in Myrtle Beach, South Carolina.
Oregon Hemp Crop- 2019 Considerations
Growing hemp in the US will be different next year, whether or not Congress finally gets its act together and passes the 2018 Farm Bill with its new hemp provisions.
Rod Quoted in the Wall Street Journal about Novel Cannabinoids
Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake.
The Rapidly Evolving Legal Status of CBD
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
Rod Publishes Peer Reviewed Article about CBD with Dr. Jamie Corroon
The “Regulatory Status of Cannabidiol in the United States: A Perspective”, an article I co-wrote with Dr. Jamie Corroon, was published this week in Cannabis and Cannabinoid Research, a peer reviewed journal.
The 2014 Farm Act Has Expired- What Now?
Congress has not yet enacted the 2018 Farm Bill. It is likely to pass within the next 8 weeks or so. However, what is the current legal status of industrial hemp now that the 2014 Farm Act has expired?
Canada’s Impending Cannabis Boom
Canada is clearly leading the way on global cannabis reform; the question remains will the United States follow suit quickly enough to capitalize on this nascent market before Canada asserts its dominance as a global provider of quality hemp and marijuana products?
DEA Reschedules Epidiolex
The DEA has rescheduled Epidiolex, a product containing CBD derived from marijuana, from schedule 1 to schedule 5.